Startups

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …

Continue ›››

Why Scandinavia is a Life Sciences Hub to Watch

Scandinavian countries are known for their active innovation in the worldwide market, including pharmaceutical and biotech fields. Numerous research institutes, …

Continue ›››

The Aging Research Is On The Rise

It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …

Continue ›››

8 Notable AI Companies in Clinical Research to Watch in 2022

The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …

Continue ›››

Pharmaceutical Artificial Intelligence in 2020: The Sector is Heating Up For Investments

Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …

Continue ›››

[Interview] Expediting Drug Discovery Through Advanced Machine Learning

The application of next-generation data analytics tools, powered by machine learning and artificial intelligence (AI) components, has become a long-term …

Continue ›››

Major VC Rounds For AI-driven Biotechs in 2020

The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …

Continue ›››

[Interview] How COVID-19 Catalyzed AI-assisted Open Science Drug Discovery

Biopharma companies are now racing to find much-needed cures against SARS-CoV-2, a virus that caused the largest global pandemic of …

Continue ›››

#Startups